We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
(+58%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
22.72%
Top 10 Holdings %
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.9M |
| 2 |
Pfizer
PFE
|
+$37.8M |
| 3 |
Honeywell
HON
|
+$33.2M |
| 4 |
JPMorgan Chase
JPM
|
+$32.4M |
| 5 |
CME Group
CME
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$33.3M |
| 2 |
PayPal
PYPL
|
+$33.1M |
| 3 |
Amazon
AMZN
|
+$32.1M |
| 4 |
PPG Industries
PPG
|
+$27.6M |
| 5 |
Autodesk
ADSK
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 14.63% |
| 3 | Healthcare | 13.67% |
| 4 | Financials | 11.93% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVFM
1426
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $402K | 0.01% |
9,479
+7,135
| +304% | +$481K |
|
|
DRNA
1427
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $402K | 0.01% |
15,840
-39,205
| -71% | -$845K |
|
1428
Calix
CALX
$2.27B
| $400K | 0.01% |
26,837
-98,073
| -79% | -$1.13M |
|
|
ILPT
1429
Industrial Logistics Properties Trust
ILPT
$613M
| $399K | 0.01% |
+19,431
| New | +$357K |
|
1430
Spero Therapeutics
SPRO
$68.9M
| $398K | 0.01% |
29,408
+9,019
| +44% | +$101K |
|
|
LVGO
1431
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $398K | 0.01% |
+5,290
| New | +$277K |
|
1432
Ezcorp Inc
EZPW
$1.82B
| $397K | 0.01% |
63,075
+48,768
| +341% | +$263K |
|
1433
Oppenheimer Holdings
OPY
$1.17B
| $395K | 0.01% |
18,109
+4,787
| +36% | +$96.8K |
|
1434
QuinStreet
QNST
$870M
| $395K | 0.01% |
37,776
-25,744
| -41% | -$248K |
|
|
PRA
1435
DELISTED
ProAssurance
PRA
| $393K | 0.01% |
+27,167
| New | +$466K |
|
1436
Belden
BDC
$4B
| $392K | 0.01% |
12,031
-974
| -7% | -$32.4K |
|
1437
White Mountains Insurance
WTM
$5.47B
| $392K | 0.01% |
442
-8
| -2% | -$7.21K |
|
|
TBIO
1438
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $390K | 0.01% |
+21,747
| New | +$328K |
|
1439
Pan American Silver
PAAS
$18.6B
| $389K | 0.01% |
12,795
-1,640
| -11% | -$38.9K |
|
|
TTOO
1440
DELISTED
T2 Biosystems, Inc
TTOO
| $389K | 0.01% |
+61
| New | +$259K |
|
1441
Tenable Holdings
TENB
$3.56B
| $387K | 0.01% |
12,996
-9,264
| -42% | -$252K |
|
1442
Wintrust Financial
WTFC
$10.7B
| $387K | 0.01% |
8,874
-65,508
| -88% | -$2.62M |
|
|
SPNE
1443
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $387K | 0.01% |
36,988
-54,887
| -60% | -$561K |
|
1444
CALL
Visa
V
$677B
| $386K | 0.01% |
+2,000
| New | +$365K |
|
|
1445
PUT
Visa
V
$677B
| $386K | 0.01% |
+2,000
| New | +$365K |
|
|
CVGW
1446
DELISTED
Calavo Growers
CVGW
| $385K | 0.01% |
6,118
+1,386
| +29% | +$83.1K |
|
1447
Sony
SONY
$123B
| $385K | 0.01% |
+27,825
| New | +$362K |
|
1448
CALL
Mastercard
MA
$477B
| $384K | 0.01% |
+1,300
| New | +$367K |
|
|
1449
PUT
Mastercard
MA
$477B
| $384K | 0.01% |
+1,300
| New | +$367K |
|
|
ACH
1450
Accendra Health
ACH
$240M
| $384K | 0.01% |
50,409
-145,432
| -74% | -$1.06M |
|
Similar funds
Squarepoint's Q2 2020 Portfolio in Review
As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.
- Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
- Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
- Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
- Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
- Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
- Squarepoint opened 906 new positions and closed 520 in Q2 2020.
- Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.
Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.